Evaluation of a commercial targeted NGS panel for tumor mutation burden assessment in FFPE tissue

被引：1
|
作者：
Fang, Peng [1 ]
Yan, Zhenyu [1 ]
Quyen Vu [2 ]
Smith, David [2 ]
Galderisi, Chad [2 ]
Spittle, Cynthia S. [1 ]
Li, Jin [1 ]
机构：
[1] MolecularMD Corp, Cambridge, MA USA
[2] MolecularMD Corp, Portland, OR USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-3614
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3614
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Analytical Validation of Tumor Mutation Burden Using a Targeted NGS Panel Compared to Whole Exome Sequencing
    Keefer, L.
    Gerding, K.
    White, J. R.
    Cerquiera, G.
    McGregor, P.
    Bryan-McNeal, K.
    Kong, E.
    Simmons, J.
    Jones, S.
    Angiuoli, S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1205 - 1205
  • [2] Tumor mutation load assessment of FFPE samples using an NGS based assay
    Chaudhary, Ruchi
    Kamat, Asha
    Tom, Warren
    Casuga, Iris
    Cyanam, Dinesh
    Brinza, Dumitru
    Au-Young, Janice
    Hyland, Fiona
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [3] Tumor mutation burden assessment on FFPE samples using a targeted next-generation sequencing assay
    Chaudhary, R.
    Cyanam, D.
    Mittal, V.
    Tom, W.
    Au-Young, J.
    Allen, C.
    Sadis, S.
    Hyland, F.
    ANNALS OF ONCOLOGY, 2018, 29
  • [4] Impact of formalin time on targeted NGS performance in FFPE tissue
    Blomquist, Thomas M.
    Crawford, Erin
    Willey, James
    Xu, Joshua
    CANCER RESEARCH, 2019, 79 (13)
  • [5] Tumor mutation burden derived from large NGS panel as biomarker for immunotherapy response
    Vuzman, Dana
    Powers, Winslow
    Huang, Xiu
    Sun, Ruobai
    Eifert, Cheryl
    Cingolani, Pablo
    Bjonnes, Andrew
    Lyle, Stephen
    Protopopov, Alexei
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] Comprehensive Development and Implementation of Good Laboratory Practice for NGS Based Targeted Panel on Solid Tumor FFPE Tissues in Diagnostics
    Chougule, Anuradha
    Jagtap, Vinita
    Nikam, Ankita
    Kale, Shrutikaa
    Nambiar, Kavya
    Bagayatkar, Priyanka
    Chandrani, Pratik
    Kaushal, Rajiv
    Noronha, Vanita
    Patil, Vijay
    Banavali, Shripad
    Prabhash, Kumar
    DIAGNOSTICS, 2022, 12 (05)
  • [7] Development of a pan-cancer NGS assay for detection of tumor mutational burden and targeted biomarkers from FFPE samples
    Cyanam, Dinesh
    Mittal, Vinay
    Khazanov, Nickolay
    Williams, Paul
    Au-Young, Janice
    Bee, Gary
    El-Difrawy, Sameh
    Ewing, Aren
    Kilzer, Jennifer
    Kraltcheva, Anelia
    Myrand, Scott
    Tseng, Yu-Ting
    Van Loy, Cristina
    Wong-Ho, Elaine
    Yang, Chenchen
    Cyanam, Dinesh
    Bandla, Santhoshi
    Tom, Warren
    Sadis, Seth
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [8] Targeted next generation sequencing for the evaluation of tumor mutation burden
    Fenizia, Francesca
    Pasquale, Raffaella
    Roma, Cristin
    Bergantino, Francesca
    Chicchinelli, Nicoletta
    Graziano, Paolo
    Botti, Gerardo
    Tatangelo, Fabiana
    Scognamiglio, Giosue
    Lambiase, Matilde
    Iannaccone, Alessia
    Normanno, Nicola
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17
  • [9] Heterogeneous mutation pattern in tumor tissue and circulating tumor DNA warrants parallel NGS panel testing
    Guo, Qiaomei
    Wang, Junlei
    Xiao, Jianfeng
    Wang, Lin
    Hu, Xiaomeng
    Yu, Wenjun
    Song, Gang
    Lou, Jiatao
    Chen, JianFeng
    MOLECULAR CANCER, 2018, 17
  • [10] Heterogeneous mutation pattern in tumor tissue and circulating tumor DNA warrants parallel NGS panel testing
    Qiaomei Guo
    Junlei Wang
    Jianfeng Xiao
    Lin Wang
    Xiaomeng Hu
    Wenjun Yu
    Gang Song
    Jiatao Lou
    JianFeng Chen
    Molecular Cancer, 17
12345